Last 36 quarters of trend data · Healthcare · Biotechnology
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -20.28 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| P/S Ratio | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| P/B Ratio | 29.63 | 39.94 | 21.04 | 9.45 | 36.52 | 2.80 | 1.36 | 3.49 | 0.74 | 0.58 | 1.15 | 0.60 | 0.31 | 1.07 | 0.83 | 0.86 | 0.84 | 0.75 | 0.67 | 1.33 | 1.37 |
| — | +1325.9% | +1444.7% | +171.2% | +4830.0% | +386.5% | +18.9% | +480.7% | +137.3% | -46.1% | +38.5% | -30.1% | -63.0% | +42.1% | +22.6% | -35.4% | -38.5% | -38.9% | -52.6% | -18.9% | -27.7% | |
| P/FCF | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBITDA | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBIT | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Operating Margin | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Net Margin | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -149.5% | -75.8% | -43.2% | -62.7% | -130.8% | -60.6% | -44.3% | -26.3% | -22.0% | -19.8% | -17.0% | -20.9% | -15.6% | -21.9% | -17.1% | -15.4% | -15.2% | -16.1% | -15.2% | -13.4% | -9.0% |
| — | -25.0% | +2.7% | -138.5% | -495.0% | -206.2% | -161.2% | -25.4% | -40.8% | +9.7% | +0.6% | -36.1% | -2.3% | -36.6% | -12.5% | -14.8% | -70.0% | -130.3% | -153.2% | -64.4% | +26.6% | |
| ROA | -66.9% | -23.3% | -17.7% | -19.9% | -25.9% | -19.6% | -18.1% | -12.5% | -11.4% | -10.8% | -9.4% | -11.6% | -8.8% | -13.0% | -10.8% | -10.1% | -10.2% | -11.1% | -10.9% | -10.0% | -6.9% |
| — | -19.1% | +2.5% | -60.0% | -128.0% | -81.5% | -92.7% | -7.5% | -29.1% | +17.3% | +13.1% | -14.4% | +14.1% | -17.4% | +0.7% | -1.3% | -48.2% | -101.8% | -127.1% | -66.2% | +13.0% | |
| ROIC | -220.8% | -115.9% | -43.7% | -71.5% | -207.0% | -120.7% | -98.2% | -61.0% | -53.0% | -29.4% | -20.6% | -31.5% | -28.7% | -41.4% | -18.8% | -12.0% | -11.5% | -21.2% | -65.7% | -64.1% | -55.5% |
| — | +4.0% | +55.5% | -17.1% | -290.5% | -310.3% | -377.1% | -94.0% | -84.7% | +28.9% | -9.7% | -161.2% | -149.0% | -95.6% | +71.4% | +81.2% | +79.2% | +86.0% | — | +44.1% | -9.5% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 1.01 | 0.86 | 1.39 | 1.01 | 2.63 | 0.93 | 0.62 | 0.47 | 0.40 | 0.35 | 0.74 | 0.68 | 0.61 | 0.55 | 0.22 | 0.43 | 0.39 | 0.35 | 0.30 | 0.27 | 0.25 |
| — | -6.9% | +123.9% | +116.1% | +562.7% | +162.7% | -15.9% | -31.5% | -34.7% | -35.3% | +234.6% | +58.8% | +54.9% | +55.0% | -27.2% | +58.7% | +59.0% | +54.1% | +221.2% | +201.7% | -10.2% | |
| Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Current Ratio | 4.72 | 2.49 | 3.54 | 4.72 | 1.78 | 3.48 | 4.62 | 6.72 | 8.42 | 10.59 | 10.12 | 6.93 | 4.96 | 5.21 | 6.25 | 9.26 | 8.30 | 8.65 | 8.94 | 11.36 | 14.81 |
| — | -28.5% | -23.5% | -29.8% | -78.8% | -67.2% | -54.3% | -3.0% | +69.7% | +103.3% | +61.8% | -25.1% | -40.3% | -39.8% | -30.0% | -18.5% | -43.9% | -59.9% | -66.4% | -63.3% | -12.7% | |
| Quick Ratio | 4.72 | 2.49 | 3.54 | 4.72 | 1.78 | 3.48 | 4.62 | 6.72 | 8.42 | 10.59 | 10.12 | 6.93 | 4.96 | 5.21 | 6.25 | 9.26 | 8.30 | 8.65 | 8.94 | 11.36 | 14.81 |
| — | -28.5% | -23.5% | -29.8% | -78.8% | -67.2% | -54.3% | -3.0% | +69.7% | +103.3% | +61.8% | -25.1% | -40.3% | -39.8% | -30.0% | -18.5% | -43.9% | -59.9% | -66.4% | -63.3% | -12.7% | |
| Interest Coverage | — | — | — | — | — | — | — | — | — | — | — | — | -10000.40 | -20046.00 | -17694.00 | -17611.00 | -19258.50 | -18124.60 | -19140.80 | -18632.00 | -11253.33 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 36 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying KOD stock.
Kodiak Sciences Inc.'s current P/E is -20.3x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Kodiak Sciences Inc.'s business trajectory between earnings reports.